GE HealthCare Files 8-K
Ticker: GEHC · Form: 8-K · Filed: 2024-09-13T00:00:00.000Z
Sentiment: neutral
Topics: sec-filing, 8-k, financials
TL;DR
GE HealthCare filed an 8-K, mostly boilerplate financial and exhibit updates.
AI Summary
GE HealthCare Technologies Inc. filed an 8-K on September 13, 2024, reporting on events from September 12, 2024. The filing primarily concerns financial statements and exhibits, with no specific material events detailed in the provided text.
Why It Matters
This filing indicates routine corporate reporting by GE HealthCare Technologies Inc. to the SEC, providing updates on financial statements and exhibits.
Risk Assessment
Risk Level: low — The filing appears to be routine and does not disclose any new material risks or significant events.
Key Numbers
- 001-41528 — Commission File Number (Identifier for GE HealthCare's SEC filings)
- 88-2515116 — IRS Employer Identification No. (Tax identification number for GE HealthCare)
Key Players & Entities
- GE HealthCare Technologies Inc. (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- September 12, 2024 (date) — Earliest event reported
- September 13, 2024 (date) — Filing date
FAQ
What specific financial statements or exhibits are being reported in this 8-K filing?
The provided text indicates that the filing concerns 'Financial Statements and Exhibits' but does not list the specific documents included.
What is the exact date of the earliest event reported in this filing?
The earliest event reported is dated September 12, 2024.
What is the principal executive office address for GE HealthCare Technologies Inc.?
The principal executive offices are located at 500 W. Monroe Street, Chicago, IL 60661.
What is the former name of GE HealthCare Technologies Inc.?
The former name was GE Healthcare Holding LLC.
What is the SIC code for GE HealthCare Technologies Inc.?
The Standard Industrial Classification (SIC) code is 3844, pertaining to X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS.
From the Filing
0001193125-24-218963.txt : 20240913 0001193125-24-218963.hdr.sgml : 20240913 20240913172432 ACCESSION NUMBER: 0001193125-24-218963 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20240912 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240913 DATE AS OF CHANGE: 20240913 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GE HealthCare Technologies Inc. CENTRAL INDEX KEY: 0001932393 STANDARD INDUSTRIAL CLASSIFICATION: X-RAY APPARATUS & TUBES & RELATED IRRADIATION APPARATUS [3844] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 882515116 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-41528 FILM NUMBER: 241298700 BUSINESS ADDRESS: STREET 1: 500 WEST MONROE STREET CITY: CHICAGO STATE: IL ZIP: 60661 BUSINESS PHONE: 833-735-1139 MAIL ADDRESS: STREET 1: 500 WEST MONROE STREET CITY: CHICAGO STATE: IL ZIP: 60661 FORMER COMPANY: FORMER CONFORMED NAME: GE Healthcare Holding LLC DATE OF NAME CHANGE: 20220603 8-K 1 d834155d8k.htm 8-K 8-K false 0001932393 0001932393 2024-09-12 2024-09-12     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549     FORM 8-K     CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) September 12, 2024       GE HEALTHCARE TECHNOLOGIES INC. (Exact name of registrant as specified in its charter)       Delaware   001-41528   88-2515116 (State or other jurisdiction of incorporation)   (Commission File Number)   (IRS Employer Identification No.) 500 W. Monroe Street , Chicago , IL     60661 (Address of principal executive offices)     (Zip Code) (Registrant’s telephone number, including area code)  (833) 735-1139   (Former name or former address, if changed since last report.)     Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):   ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)   ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)   ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))   ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act:   Title of each class   Trading Symbol(s)   Name of each exchange on which registered Common stock, par value $0.01 per share   GEHC   The Nasdaq Stock Market LLC Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter). Emerging growth company  ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards pursuant to Section 13(a) of the Exchange Act. ☐       Item 8.01. Other Events. On September 12, 2024, GE HealthCare Technologies Inc. (the “Company”) announced the commencement and pricing of an underwritten offering (the “Offering”) of 15,000,000 shares of its common stock (the “GEHC Shares”) at a public offering price of $86.00 per share. The Company is not selling any shares of common stock and will not receive any proceeds from the sale of the GEHC Shares in the Offering or from the debt-for